Table 1.
Data source | Participants | Findings | Reference |
---|---|---|---|
Gulf CARE | 5,005 patients hospitalized with acute HF | ACS was the most common precipitating factor for new-onset HF (39.2%) and non-compliance with medications the most common precipitating factor for decompensated chronic HF (27.8%) | [30] |
| |||
Swedish Heart Failure Registry | 21,496 patients with HF | Iron deficiency testing only performed in 27% of patients; 49% of those tested had iron deficiency which was associated with recurrent hospitalization | [31] |
| |||
GTWG-Heart Failure Registry | 1,551 patients hospitalized for HFrEF and discharged on sacubitril/valsartan and 7,857 discharged on ACEi/ARB | Prescription of sacubitril/valsartan was associated with reduced post-discharge mortality and all-cause hospitalization compared with ACEi/ARB | [32] |
| |||
Korean Registry of Acute Myocardial Infarction for Regional Cardio-Cerebrovascular Centres | 11,700 patients with acute MI | ST-elevation and non-ST-elevation MI occurred in 43% and 57%, with case fatality within 12 months of 10% | [33] |
| |||
EORP-Atrial Fibrillation III Registry | 8,306 patients with AF | Median age of the registry cohort was 69 years, with patients enrolled across 31 participating countries with future follow-up to assess adherence to guidelines and adverse events | [34] |
ACEi, angiotensin converting enzyme inhibitor; ACS, acute coronary syndrome; AF, atrial fibrillation; ARB, angiotensin receptor blocker; HF, heart failure; MI, myocardial infarction; RWD, real-world data; Gulf CARE, Gulf aCute heArt failuRe rEgistry; GTWG, Get With The Guidelines; EORP, EUR Observational Research Programme.